Published in J Anat on December 02, 2011
Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol (2013) 2.52
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.16
Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS One (2012) 0.85
A stem-cell based bioassay to critically assess the pathology of dysfunctional neuromuscular junctions. PLoS One (2014) 0.83
Aggregation of Human Eyelid Adipose-derived Stem Cells by Human Body Fluids. Balsaenggwa Saengsig (2012) 0.82
Microfluidic device for the formation of optically excitable, three-dimensional, compartmentalized motor units. Sci Adv (2016) 0.78
Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons. Sci Rep (2015) 0.77
Generation of Functional Neuromuscular Junctions from Human Pluripotent Stem Cell Lines. Front Cell Neurosci (2015) 0.76
Creating Interactions between Tissue-Engineered Skeletal Muscle and the Peripheral Nervous System. Cells Tissues Organs (2016) 0.75
On-chip, multisite extracellular and intracellular recordings from primary cultured skeletal myotubes. Sci Rep (2016) 0.75
A system for studying mechanisms of neuromuscular junction development and maintenance. Development (2016) 0.75
Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases. Annu Rev Pharmacol Toxicol (2015) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (2008) 14.09
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (2009) 12.99
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol (2001) 11.53
Directed differentiation of embryonic stem cells into motor neurons. Cell (2002) 9.76
Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat Rev Genet (2000) 9.54
Specification of motoneurons from human embryonic stem cells. Nat Biotechnol (2005) 7.74
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature (2009) 7.04
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol (2004) 6.26
Development of the vertebrate neuromuscular junction. Annu Rev Neurosci (1999) 5.81
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol (2009) 3.73
Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry (2009) 3.35
Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci (2000) 3.14
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet (2007) 3.09
Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci (2006) 3.06
Spinal muscular atrophy. Lancet (2008) 2.92
Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod (2003) 2.89
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet (2008) 2.82
Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci (2009) 2.71
Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med (2007) 2.61
Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med (2009) 2.57
Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett (2009) 2.48
Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum Mol Genet (2008) 2.35
Motor neuron diversity in development and disease. Annu Rev Neurosci (2010) 2.18
Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet (2002) 2.13
Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc (2009) 2.11
Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp Neurol (2005) 2.00
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2006) 1.97
Human feeder layers for human embryonic stem cells. Biol Reprod (2003) 1.94
Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr Biol (2003) 1.92
Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2007) 1.80
Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell (2011) 1.71
Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet (2010) 1.70
Synaptic potentials recorded in cell cultures of nerve and muscle. Science (1970) 1.47
Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell (2010) 1.42
An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet (2009) 1.42
Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum Mol Genet (2011) 1.37
A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech (2010) 1.36
Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet (2011) 1.32
Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet (1995) 1.30
Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol (2007) 1.29
Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol Appl Neurobiol (2010) 1.28
Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet (2009) 1.26
Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J Neurosci (2008) 1.25
Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity. PLoS One (2009) 1.24
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state. Nat Commun (2011) 1.20
Differential effects of neurotrophins and schwann cell-derived signals on neuronal survival/growth and synaptogenesis. J Neurosci (2003) 1.17
Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions. Trends Neurosci (1996) 1.15
De novo formation of neuro-muscular junctions in tissue culture. Nature (1968) 1.09
Neuromuscular transmission in cultures of adult human and rodent skeletal muscle after innervation in vitro by fetal rodent spinal cord. J Neurobiol (1970) 0.98
Neuromuscular junction formation between human stem-cell-derived motoneurons and rat skeletal muscle in a defined system. Tissue Eng Part C Methods (2010) 0.97
Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytol (2004) 0.96
Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons. Neurology (1987) 0.94
Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. J Neurophysiol (2002) 0.94
Innervation in cultures of fetal rodent skeletal muscle by organotypic explants of spinal cord from different animals. Z Zellforsch Mikrosk Anat (1970) 0.91
Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci (2008) 0.89
Neurodegenerative disease-specific induced pluripotent stem cell research. Exp Cell Res (2010) 0.89
Electron microscopy of the in vitro development of mammalian motor end plates. Ann N Y Acad Sci (1971) 0.88
Musculoskeletal differentiation of cells derived from human embryonic germ cells. Stem Cells (2005) 0.87
Regeneration and innervation in cultures of adult mammalian skeletal muscle coupled with fetal rodent spinal cord. Exp Neurol (1972) 0.84
Duchenne dystrophic muscle develops lesions in long-term coculture with mouse spinal cord. Muscle Nerve (1986) 0.82
The development of nerve-muscle junctions in monolayer cultures of embryonic spinal cord and skeletal muscle cells. J Cell Biol (1969) 0.81
The effect of serum from ALS patients on organotypic nerve and muscle tissue cultures. Acta Neuropathol (1975) 0.79
Growth of diseased human muscle in combined cultures with normal mouse embryonic spinal cord. J Neurol Sci (1975) 0.78
A comparison of growth, differentiation, activity and action currents of heart and skeletal muscle in tissue culture. Anat Rec (1946) 0.76
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci (2011) 5.24
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol (2012) 3.15
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet (2007) 3.09
Improving the translational hit of experimental treatments in multiple sclerosis. Mult Scler (2010) 2.73
Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells (2007) 2.20
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14
Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells (2009) 1.96
Embryonic stem cell-derived neural progenitors display temporal restriction to neural patterning. Stem Cells (2006) 1.82
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res (2011) 1.76
Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet (2009) 1.76
Dopamine from the brain promotes spinal motor neuron generation during development and adult regeneration. Dev Cell (2013) 1.74
Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med (2012) 1.63
A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin. Stem Cells (2007) 1.60
WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering. Curr Biol (2012) 1.55
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep (2012) 1.50
Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells. Lancet (2004) 1.50
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A (2013) 1.49
Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol (2006) 1.49
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain (2005) 1.46
Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation. Eur J Neurosci (2004) 1.45
Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci (2003) 1.45
Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One (2013) 1.43
A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur J Neurosci (2005) 1.39
Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol Cell Proteomics (2007) 1.35
Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet (2011) 1.32
Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain (2007) 1.31
SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy. Hum Mol Genet (2010) 1.30
VAPB interacts with and modulates the activity of ATF6. Hum Mol Genet (2008) 1.26
A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells (2006) 1.26
Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Mol Cells (2009) 1.26
Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease. Hum Mol Genet (2009) 1.26
Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet (2009) 1.26
Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity. PLoS One (2009) 1.24
Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci (2011) 1.23
Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci U S A (2010) 1.22
Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion. Brain (2006) 1.20
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy. Dis Model Mech (2011) 1.15
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum Mol Genet (2006) 1.14
The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol Biol Cell (2005) 1.13
Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol (2010) 1.13
mGluR5 regulates glutamate-dependent development of the mouse somatosensory cortex. J Neurosci (2008) 1.12
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Sci Transl Med (2013) 1.11
Multipotent skin-derived precursors: from biology to clinical translation. Curr Opin Biotechnol (2009) 1.09
Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy. J Clin Invest (2014) 1.08
Human stem cell-derived neurons: a system to study human tau function and dysfunction. PLoS One (2010) 1.07
Cell-mediated neuroprotection in a mouse model of human tauopathy. J Neurosci (2010) 1.07
Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis. J Neuropathol Exp Neurol (2008) 1.07
Combining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivo. PLoS Genet (2012) 1.04
Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Hum Mol Genet (2012) 1.04
Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds). Genome Biol (2008) 1.02
Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells (2006) 1.02
Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology. J Anat (2008) 1.01
Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain (2012) 1.00
High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology. Stem Cell Reports (2013) 0.99
Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS One (2008) 0.99
Synaptic Ras GTPase activating protein regulates pattern formation in the trigeminal system of mice. J Neurosci (2006) 0.99
A neurological phenotype in mice with DNA repair gene Ercc1 deficiency. DNA Repair (Amst) (2007) 0.98
Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor. J Neuropathol Exp Neurol (2005) 0.97
Involvement of protein kinase A in patterning of the mouse somatosensory cortex. J Neurosci (2006) 0.97
Thrombotic microangiopathy associated with interferon beta. N Engl J Med (2014) 0.97
A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J Neurosci (2006) 0.96
What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex (2011) 0.95
SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Hum Mol Genet (2013) 0.95
Maturation of AMPAR composition and the GABAAR reversal potential in hPSC-derived cortical neurons. J Neurosci (2014) 0.94
An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J Neuroimmunol (2008) 0.93
ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum Mol Genet (2011) 0.93
Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Brain (2013) 0.92
Studying synapses in human brain with array tomography and electron microscopy. Nat Protoc (2013) 0.89
Induction of cell stress in neurons from transgenic mice expressing yellow fluorescent protein: implications for neurodegeneration research. PLoS One (2011) 0.89
Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci (2008) 0.89
Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene. Mol Neurodegener (2007) 0.88
Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose. PLoS One (2010) 0.87
Protein product of CLN6 gene responsible for variant late-onset infantile neuronal ceroid lipofuscinosis interacts with CRMP-2. J Neurosci Res (2009) 0.87
Verbal fluency as a rapid screening test for cognitive impairment in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2011) 0.87
Development of a supported self-directed learning approach for anatomy education. Anat Sci Educ (2011) 0.86
Origins of gliogenic stem cell populations within adult skin and bone marrow. Stem Cells Dev (2010) 0.86
Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis. Acta Neuropathol (2009) 0.86
Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. J Neurochem (2002) 0.86
Human embryonic stem cell-derived neurons as a tool for studying neuroprotection and neurodegeneration. Mol Neurobiol (2010) 0.85